Correlation Between PDS Biotechnology and Exicure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Exicure, you can compare the effects of market volatilities on PDS Biotechnology and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Exicure.

Diversification Opportunities for PDS Biotechnology and Exicure

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between PDS and Exicure is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Exicure go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Exicure

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Exicure. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 4.85 times less risky than Exicure. The stock trades about -0.32 of its potential returns per unit of risk. The Exicure is currently generating about 0.51 of returns per unit of risk over similar time horizon. If you would invest  241.00  in Exicure on August 29, 2024 and sell it today you would earn a total of  2,528  from holding Exicure or generate 1048.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Exicure

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Exicure 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.

PDS Biotechnology and Exicure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Exicure

The main advantage of trading using opposite PDS Biotechnology and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.
The idea behind PDS Biotechnology Corp and Exicure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets